186 related articles for article (PubMed ID: 21076874)
1. Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer.
Lu D; Yu X; Du Y
Mol Biol Rep; 2011 Apr; 38(4):2409-16. PubMed ID: 21076874
[TBL] [Abstract][Full Text] [Related]
2. The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies.
Tang K; Li Y; Zhang Z; Gu Y; Xiong Y; Feng G; He L; Qin S
BMC Cancer; 2010 Oct; 10():575. PubMed ID: 20969746
[TBL] [Abstract][Full Text] [Related]
3. Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.
Zhuo X; Song J; Liao J; Zhou W; Ye H; Li Q; Xiang Z; Zhang X
Medicine (Baltimore); 2016 Oct; 95(43):e5156. PubMed ID: 27787372
[TBL] [Abstract][Full Text] [Related]
4. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.
Zhou GW; Hu J; Li Q
World J Gastroenterol; 2010 Jun; 16(23):2949-53. PubMed ID: 20556843
[TBL] [Abstract][Full Text] [Related]
5. Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.
Deng XD; Gao Q; Zhang B; Zhang LX; Zhang W; Mu Er ZE; Xie Y; Ma Y; Liu Y
Asian Pac J Cancer Prev; 2014; 15(12):4977-82. PubMed ID: 24998574
[TBL] [Abstract][Full Text] [Related]
6. CYP2E1 RsaI/PstI polymorphism and liver cancer risk among east Asians: a HuGE review and meta-analysis.
Tian Z; Li YL; Zhao L; Zhang CL
Asian Pac J Cancer Prev; 2012; 13(10):4915-21. PubMed ID: 23244081
[TBL] [Abstract][Full Text] [Related]
7. Updated meta-analysis of the association between CYP2E1 RsaI/PstI polymorphisms and lung cancer risk in Chinese population.
Wang YD; Yang HY; Liu J; Wang HY
Asian Pac J Cancer Prev; 2014; 15(13):5411-6. PubMed ID: 25040958
[TBL] [Abstract][Full Text] [Related]
8. CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature.
Boccia S; De Lauretis A; Gianfagna F; van Duijn CM; Ricciardi G
Carcinogenesis; 2007 Jan; 28(1):101-6. PubMed ID: 16837478
[TBL] [Abstract][Full Text] [Related]
9. CYP2E1 RsaI/PstI polymorphisms contributed to oral cancer susceptibility: a meta-analysis.
Guo Y; Zhou S; Liu F; Zhang B
Int J Clin Exp Pathol; 2015; 8(11):14685-92. PubMed ID: 26823792
[TBL] [Abstract][Full Text] [Related]
10. CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians.
Zhan P; Wang J; Zhang Y; Qiu LX; Zhao SF; Qian Q; Wei SZ; Yu LK; Song Y
Lung Cancer; 2010 Jul; 69(1):19-25. PubMed ID: 19796841
[TBL] [Abstract][Full Text] [Related]
11. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z
PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075
[TBL] [Abstract][Full Text] [Related]
12. CYP2E1 polymorphisms and nasopharyngeal carcinoma risk: a meta-analysis.
Yao K; Qin H; Gong L; Zhang R; Li L
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):253-259. PubMed ID: 27491320
[TBL] [Abstract][Full Text] [Related]
13. CYP2E1 RsaI/PstI polymorphism and risk of anti-tuberculosis drug-induced liver injury: a meta-analysis.
Deng R; Yang T; Wang Y; Tang N
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1574-81. PubMed ID: 23131254
[TBL] [Abstract][Full Text] [Related]
14. CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.
Zhuo W; Zhang L; Wang Y; Ling J; Zhu B; Chen Z
PLoS One; 2012; 7(11):e48265. PubMed ID: 23139769
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies.
Leng WD; Zeng XT; Chen YJ; Duan XL; Niu YM; Long RP; Luo ZX
Exp Ther Med; 2012 Nov; 4(5):938-948. PubMed ID: 23226753
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.
Liu S; Park JY; Schantz SP; Stern JC; Lazarus P
Oral Oncol; 2001 Jul; 37(5):437-45. PubMed ID: 11377232
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism in cytochrome P450 2E1 and alcoholic pancreatitis sus-ceptibility: a meta-analysis.
Wu C; Wu D; Liu Y; Zhong Y
Hippokratia; 2018; 22(2):60-67. PubMed ID: 31217677
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.
Lin YC; Wu X; Zhou XQ; Ren R; Su ZX; Liu CX
Int J Clin Exp Med; 2015; 8(6):8927-37. PubMed ID: 26309545
[TBL] [Abstract][Full Text] [Related]
19. CYP2E1 PstI polymorphism increases cervical neoplasia risk: a meta-analysis.
Wang X; He Y
Genet Mol Res; 2015 May; 14(2):5203-9. PubMed ID: 26125714
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk.
Cury NM; Russo A; Galbiatti AL; Ruiz MT; Raposo LS; Maniglia JV; Pavarino EC; Goloni-Bertollo EM
Mol Biol Rep; 2012 Feb; 39(2):1055-63. PubMed ID: 21590276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
